Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients

Affiliations

Sabine Riethdorf et al. Breast Cancer Res. 2009.

. 2009;11 Suppl 3(Suppl 3):S10.

doi: 10.1186/bcr2429. Epub 2009 Dec 18.

¹ Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

No abstract available

References

1. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8:329–340. doi: 10.1038/nrc2375. - DOI - PubMed
1. Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastasis. Nat Clin Pract Oncol. 2009;6:339–351. - PubMed
1. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4:448–456. doi: 10.1038/nrc1370. - DOI - PubMed
1. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR, Riethmuller G. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst. 1993;85:1419–1424. doi: 10.1093/jnci/85.17.1419. - DOI - PubMed
1. Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Janicke F, Pantel K. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res. 2005;11:3678–3685. doi: 10.1158/1078-0432.CCR-04-2469. - DOI - PubMed